These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 26753452)

  • 1. Generic Medicines in Croatia--Regulatory Aspects and Statistics.
    Zulfikari S; Sučić AF; Meštrović K; Barbarić MP; Mandarić V; Zorić N; Tomić S
    Coll Antropol; 2015 Jun; 39(2):363-70. PubMed ID: 26753452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of purity profiles of generic lisinopril tablets marketed in Croatia.
    Benković G; Sokolić M; Cudina B; Zulj RT; Tomić S
    Coll Antropol; 2013 Jun; 37(2):601-6. PubMed ID: 23941010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulating medicines in Croatia: five-year experience of Agency for Medicinal Products and Medical Devices.
    Tomić S; Filipović Sucić A; Plazonić A; Truban Zulj R; Macolić Sarinić V; Cudina B; Ilić Martinac A
    Croat Med J; 2010 Apr; 51(2):104-12. PubMed ID: 20401952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Main Reasons for Registration Application Refusal of Generic and Similar Pharmaceutical Drug Products by the Brazilian Health Regulatory Agency (ANVISA).
    do Carmo AC; Piras SS; Rocha NF; Gratieri T
    Biomed Res Int; 2017; 2017():7894937. PubMed ID: 28280742
    [No Abstract]   [Full Text] [Related]  

  • 5. A review of the differences and similarities between generic drugs and their originator counterparts, including economic benefits associated with usage of generic medicines, using Ireland as a case study.
    Dunne S; Shannon B; Dunne C; Cullen W
    BMC Pharmacol Toxicol; 2013 Jan; 14():1. PubMed ID: 23289757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overview of the European Medicines Agency's Experience With Biowaivers in Centralized Applications.
    Lenić I; Blake K; Garcia-Arieta A; Potthast H; Welink J
    Clin Transl Sci; 2019 Sep; 12(5):490-496. PubMed ID: 31046182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Equivalence in Active Pharmaceutical Ingredient of Generic Antihypertensive Medicines Available in Nigeria (EQUIMEDS): A Case for Further Surveillance.
    Redfern J; Kaur H; Adedoyin RA; Ofori S; Anchala R; Vamadevan AS; De Andrade L; Zelaya J; Balabanova D; Sani MU
    Glob Heart; 2019 Sep; 14(3):327-333. PubMed ID: 31451241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A survey exploring knowledge and perceptions of general practitioners towards the use of generic medicines in the northern state of Malaysia.
    Chua GN; Hassali MA; Shafie AA; Awaisu A
    Health Policy; 2010 May; 95(2-3):229-35. PubMed ID: 20044165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generic medicines: issues and relevance for global health.
    Rana P; Roy V
    Fundam Clin Pharmacol; 2015 Dec; 29(6):529-42. PubMed ID: 26405851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Licensing of Orphan Medicinal Products-Use of Real-World Data and Other External Data on Efficacy Aspects in Marketing Authorization Applications Concluded at the European Medicines Agency Between 2019 and 2021.
    Naumann-Winter F; Wolter F; Hermes U; Malikova E; Lilienthal N; Meier T; Kalland ME; Magrelli A
    Front Pharmacol; 2022; 13():920336. PubMed ID: 36034814
    [No Abstract]   [Full Text] [Related]  

  • 11. Switching from originator brand medicines to generic equivalents in selected developing countries: how much could be saved?
    Cameron A; Mantel-Teeuwisse AK; Leufkens HG; Laing RO
    Value Health; 2012; 15(5):664-73. PubMed ID: 22867775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conformity of package inserts information to regulatory requirements among selected branded and generic medicinal products circulating on the East African market.
    Sillo HB; Masota NE; Kisoma S; Rago L; Mgoyela V; Kaale EA
    PLoS One; 2018; 13(5):e0197490. PubMed ID: 29787579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Affordability and availability of off-patent drugs in the United States-the case for importing from abroad: observational study.
    Gupta R; Bollyky TJ; Cohen M; Ross JS; Kesselheim AS
    BMJ; 2018 Mar; 360():k831. PubMed ID: 29555641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knowledge, attitudes and practices of community pharmacists on generic medicines in Palestine: a cross-sectional study.
    Shraim NY; Al Taha TA; Qawasmeh RF; Jarrar HN; Shtaya MAN; Shayeb LA; Sweileh WM
    BMC Health Serv Res; 2017 Dec; 17(1):847. PubMed ID: 29282055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Generic drugs: we must cut pharmaceutical spending but undertaking drug quality].
    Carrillo Norte JA; Postigo Mota S
    Rev Enferm; 2012 Feb; 35(2):10-9. PubMed ID: 22670381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of the Medicines Control Council backlog and fast-track review system on access to innovative and new generic and biosimilar medicines of public health importance in South Africa.
    Leng HM; Pollock AM; Sanders D
    S Afr Med J; 2016 Mar; 106(4):43-6. PubMed ID: 27032846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generic medicines: solutions for a sustainable drug market?
    Dylst P; Vulto A; Godman B; Simoens S
    Appl Health Econ Health Policy; 2013 Oct; 11(5):437-43. PubMed ID: 23846572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Retrospective Analysis of Applications for Registration of Generic Medicines Processed by the Medicines Control Authority of Zimbabwe.
    Samunda BT; Sithole T; Khoza S
    Ther Innov Regul Sci; 2023 Mar; 57(2):287-294. PubMed ID: 36269550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Information provided by generic and brand-name pharmaceutical manufacturers in response to a request.
    Fernandez-Llimos F; Vazquez Gomez I
    Pharm World Sci; 2007 Dec; 29(6):683-7. PubMed ID: 17464571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modified Regulatory Pathways to Approve Generic Drugs in the US and a Systematic Review of Their Outcomes.
    Kesselheim AS; Polinski JM; Fulchino LA; Isaman DL; Gagne JJ
    Drugs; 2015 Apr; 75(6):633-50. PubMed ID: 25822610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.